VER-3323 is a drug which acts as a selective agonist for both the 5-HT<sub>2B</sub> and 5-HT<sub>2C</sub> serotonin receptor subtypes, with moderate selectivity for 5-HT<sub>2C</sub>, but relatively low affinity for 5-HT<sub>2A</sub>. It has potent anorectic effects in animal studies.